Ginkgo Bioworks Holdings, Inc. (DNA)
7.225
-0.32
(-4.18%)
USD |
NYSE |
Aug 26, 16:00
7.37
+0.14
(+2.01%)
After-Hours: 20:00
Ginkgo Bioworks Holdings Debt to Equity Ratio : 0.9615 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.9615 |
| March 31, 2026 | 0.9268 |
| December 31, 2025 | 0.8649 |
| September 30, 2025 | 0.7554 |
| June 30, 2025 | 0.6996 |
| March 31, 2025 | 0.6712 |
| December 31, 2024 | 0.6532 |
| September 30, 2024 | 0.5584 |
| June 30, 2024 | 0.5429 |
| March 31, 2024 | 0.2375 |
| December 31, 2023 | 0.2204 |
| September 30, 2023 | 0.3222 |
| Date | Value |
|---|---|
| June 30, 2023 | 0.2733 |
| March 31, 2023 | 0.2514 |
| December 31, 2022 | 0.2549 |
| September 30, 2022 | 0.0417 |
| June 30, 2022 | 0.0336 |
| March 31, 2022 | 0.0173 |
| December 31, 2021 | 0.0153 |
| September 30, 2021 | 0.0105 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.0369 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Sotera Health Co. | 3.407 |
| Caris Life Sciences, Inc. | 0.7645 |
| BillionToOne, Inc. | 0.2681 |
| Quest Diagnostics, Inc. | 0.8493 |
| Labcorp Holdings, Inc. | 0.7861 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 990.05M |
| Total Liabilities (Quarterly) | 569.76M |
| Shareholders Equity (Quarterly) | 420.28M |
| Current Ratio | 4.572 |
| Net Debt Paydown Yield | 1.01% |